ArticleZeitschrift fur Rheumatologie2021

Comparative study of the efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib versus methotrexate for disease-modifying antirheumatic drug-naïve patients with rheumatoid arthritis.

Y-K Sung et al.PubMed ↗Publisher ↗

No numbers read from the abstract.